Aspen Neuroscience Wins FDA RMAT Designation for ANPD001
SAN DIEGO, July 30, 2026 Aspen Neuroscience, Inc. has received Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S....
Autologous Cell Therapy
Advertisement
EVERSANA, Innovacell Partner to Advance ICEF15 Cell Therapy
CHICAGO, July 30, 2026 EVERSANA has been selected by Innovacell Inc. as its exclusive U.S. commercialization partner to support...
Aspen Neuroscience Completes Cohort 4 in ASPIRO Parkinson’s Trial
SAN DIEGO, June 30, 2026 Aspen Neuroscience, Inc. has announced the successful completion of Cohort 3 and Cohort 4...
AVITA Medical Reports First U.K. Clinical Success with RECELL GO
VALENCIA, Calif., June 18, 2026 AVITA Medical, Inc. announced positive first U.K. clinical experience with its RECELL GO® automated...
Made Scientific Selected for Columbia’s NOVAKnee Program
PRINCETON, N.J., June 1, 2026 Made Scientific has been selected as the manufacturing partner for Columbia University’s NOVAKnee program,...
Advertisements
Aspen Advances Parkinson’s Therapy with Commercial ANPD001 Formulation
SAN DIEGO, Sept. 25, 2025 (cGxP.wire) – Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, announced...
Advertisement
